DARE - CIK 0001401914
The table below shows Dare Bioscience, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.71M | $15.70M | $10.48M | $34.67M | $51.67M | $4.67M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $27.06M |
| $18.45M |
| $17.54M |
| $43.04M |
| $55.30M |
| $6.98M |
| Property, plant & equipment | $1.56M | $1.34M | $655.98K | $64.91K | $26.04K | $37.93K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $32.47M | $22.10M | $21.28M | $43.83M | $55.81M | $7.55M |
| Accounts payable | $1.20M | $1.46M | $3.39M | $2.03M | $2.10M | $1.02M |
| Total current liabilities | $23.69M | $21.61M | $20.48M | $31.62M | $16.05M | $7.66M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $29.63M | $28.11M | $26.33M | $32.71M | $17.05M | $8.70M |
| Retained earnings | -$188.69M | -$175.29M | -$171.24M | -$141.07M | -$110.13M | -$71.43M |
| Total equity | $2.84M | -$6.01M | -$5.05M | $11.11M | $38.75M | -$1.15M |